PT Bundamedik Tbk (IDX:BMHS)
197.00
+3.00 (1.55%)
Nov 20, 2026, 4:07 PM WIB
PT Bundamedik Tbk Revenue
PT Bundamedik Tbk had revenue of 419.66B IDR in the quarter ending September 30, 2026, with 5.68% growth. This brings the company's total for the last twelve months to 1.65T, up 6.06% year-over-year. In the year 2025, PT Bundamedik Tbk had annual revenue of 1.61T with 3.84% growth. That makes PT Bundamedik Tbk the 23,537th largest company in the world by revenue and 370th in Indonesia.
Revenue (ttm)
1.65T
Revenue Growth
+6.06%
P/S Ratio
1.03
Revenue / Employee
884.82M
Employees
1,861
Market Cap
1.69T
Revenue by Segment
- Healthcare Services 1.66T 88.7%
- Others 211.18B 11.3%
Fiscal year ended Dec 31, 2025 See the full PT Bundamedik Tbk breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.61T | 59.66B | 3.84% |
| Dec 31, 2024 | 1.55T | 66.49B | 4.47% |
| Dec 31, 2023 | 1.49T | -170.49B | -10.28% |
| Dec 31, 2022 | 1.66T | -232.11B | -12.28% |
| Dec 31, 2021 | 1.89T | 742.66B | 64.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 7.73T |
| PT Medikaloka Hermina Tbk | 7.37T |
| PT Famon Awal Bros Sedaya Tbk | 2.77T |
| PT Sarana Meditama Metropolitan Tbk | 2.03T |
| PT Murni Sadar Tbk | 1.57T |
| PT Nitrasanata Dharma | 942.27B |
| PT Metro Healthcare Indonesia Tbk | 571.05B |
| PT Kedoya Adyaraya Tbk | 530.71B |